Categories AlphaGraphs, Earnings, Health Care
Thermo Fisher Scientific (TMO) Q4 adj. earnings rise; revenue down 5%
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease in revenues.
Fourth-quarter revenues declined 5% annually to $10.89 billion, mainly reflecting weak performance by the Laboratory Products and Life Sciences Solutions segments.
Adjusted earnings, meanwhile, moved up to $5.67 per share in the December quarter from $5.40 per share a year earlier. The reported profit was $1.63 billion or $4.20 per share, compared to $1.58 billion or $4.01 per share in the prior-year quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
